Gag-mediated autophagy in HIV persistence

Information

  • Research Project
  • 9193336
  • ApplicationId
    9193336
  • Core Project Number
    R21AI116256
  • Full Project Number
    7R21AI116256-02
  • Serial Number
    116256
  • FOA Number
    PA-12-162
  • Sub Project Id
  • Project Start Date
    6/23/2015 - 9 years ago
  • Project End Date
    5/31/2017 - 7 years ago
  • Program Officer Name
    KUO, LILLIAN S.
  • Budget Start Date
    10/12/2015 - 9 years ago
  • Budget End Date
    5/31/2016 - 8 years ago
  • Fiscal Year
    2015
  • Support Year
    02
  • Suffix
  • Award Notice Date
    1/13/2016 - 8 years ago

Gag-mediated autophagy in HIV persistence

? DESCRIPTION (provided by applicant): Human immunodeficiency virus (HIV) infection creates a persistent reservoir in resting CD4 T cells that is maintained during antiretroviral therapy (ART). These reservoir CD4 T cells threaten recrudescence even after prolonged treatment and are a major impediment to AIDS cure. Our goals are to discover the mechanisms responsible for persistence of latent CD4 T cells and develop strategies to allow their elimination during a relevant time interval. We hypothesize that HIV developed a capacity to stimulate anti-apoptotic activities as a key part of the latency mechanism, which might account for the greatly increased half-life of reservoir cells and their evasion of immune clearance. Some studies indicated that low-level viral gene expression exists in some of the latently infected cells, even f they are not releasing infectious virus. Particularly, directly infected resting CD4 T cells produc Gag without spreading infection in a model of HIV latency. In this project, we focus on HIV Gag polyprotein, which induces autophagy in CD4 T cells and protect cells from apoptosis. Using some in vitro models of latency, we test whether Gag induced autophagy protect HIV latently infected cells from stress- induced apoptosis and CTL-mediated immune clearance, and whether specific autophagy inhibitors eliminate the resistance and help clear the latent cells. We will also map the active regions within Gag polyprotein and define the cytoprotective mechanisms of Gag-mediated autophagy. Specifically, we test whether Gag- mediated autophagy protect cells by selectively degrading pro-apoptotic proteins, damaged mitochondria and CTL-derived granzyme B. Chloroquine and its analog hydroxychloroquine are used widely as anti-malarial or anti-rheumatoid agents and are now used for cancer therapy as autophagy inhibitors. It is reasonable that our in vitro studies can provide the justification for animal modls or clinical trials testing whether autophagy inhibitors help eradicate HIV latent reservoir.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R21
  • Administering IC
    AI
  • Application Type
    7
  • Direct Cost Amount
    135755
  • Indirect Cost Amount
    13576
  • Total Cost
    149331
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
  • Funding ICs
    NIAID:149331\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    AIP
  • Study Section Name
    AIDS Immunology and Pathogenesis Study Section
  • Organization Name
    AMERICAN GENE TECHNOLOGIES INTERNATIONAL
  • Organization Department
  • Organization DUNS
    830791054
  • Organization City
    ROCKVILLE
  • Organization State
    MD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    208503307
  • Organization District
    UNITED STATES